MedTrace Logo

CBD, Nutrient Metabolism and Energy Intake

NCT05618756 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2025-02-06

No results posted yet for this study

Summary

CBD may affect metabolic control and energy intake. However, there is currently little data regarding these specific outcomes in humans. Therefore, this study will investigate whether a single 300 mg dose of CBD can improve metabolic control following a meal and/or reduce energy intake at a subsequent meal. Healthy, adult volunteers will complete two conditions in a crossover design, comparing outcomes following both CBD and placebo supplementation.

Conditions

  • Glucose Metabolism Disorders (Including Diabetes Mellitus)
  • Lipid Metabolism Disorders
  • Appetitive Behavior

Interventions

DIETARY_SUPPLEMENT

Acute oral CBD supplementation

1 ml hemp oil containing 300 mg CBD, within gelatin capsules, ingested orally.

DIETARY_SUPPLEMENT

Acute oral placebo supplementation

1 ml hemp oil containing no CBD, within gelatin capsules, ingested orally.

Sponsors & Collaborators

  • Loughborough University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-30
Primary Completion
2022-04-30
Completion
2022-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05618756 on ClinicalTrials.gov